Skip to main content
← CELLOGRAM
Terms of Service

Terms of Service

Business operator: CLEARMED Co., Ltd. (the "Company")
Representative: Ahn Hyun Su
Business Registration No.: 311-87-03494
Address: B1 171, 524 Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
Date of notice: September 28, 2026
Effective date: October 5, 2026

Notice of revision — These Terms take effect on October 5, 2026. You can review the changes in the before-and-after comparison in the Addenda below.

The purpose of these Terms is to set out the conditions and process for using the website cellogram.co.kr (including the alternate domain clearmed.co.kr; the "Site") operated by CLEARMED Co., Ltd. (the "Company"), the rights, obligations and responsibilities of the Company and users, and other necessary matters. These Terms reflect the spirit of the Korea Fair Trade Commission's Standard Terms and Conditions for Electronic Commerce (No. 10023), adjusted to suit the characteristics of a B2B site that provides information.

Article 1 (Purpose)

The purpose of these Terms is to set out the rights, obligations and responsibilities of the Company and users in connection with users' use of the information, materials and inquiries provided by the Company through the Site (the "Service").

Article 2 (Definitions)

  1. "Site" means cellogram.co.kr and clearmed.co.kr, operated by the Company.
  2. "User" means a person who accesses the Site and uses the Service in accordance with these Terms. The Company's Service is intended primarily for B2B medical professionals (hospitals and clinics, aesthetic clinics, dealers of medical devices and cosmetics, and people in academia).
  3. "Service" means the product information and academic materials provided by the Company through the Site, and its handling of inquiries and consultations submitted through the inquiry form.
  4. "Content" means all text, images, videos, shaders, designs, logos, trademarks and other material posted on the Site.

Article 3 (Effect and Amendment of the Terms)

  1. These Terms take effect upon being posted on the Site.
  2. The Company may amend these Terms to the extent that doing so does not violate relevant laws such as the Act on the Regulation of Terms and Conditions.
  3. When amending the Terms, the Company will specify the reasons for the amendment and the effective date and announce them on the Site starting 7 days before the effective date (30 days before for changes unfavorable to users).
  4. Amended Terms apply from their effective date. Users who do not agree to the amended Terms may stop using the Site.

Article 4 (Description of the Service)

The Service provided by the Company through the Site consists of the following:

  1. Information about the Company and its products (CELLOGRAM ECM Booster, etc.)
  2. Publication of scientific evidence and academic materials
  3. Receiving and responding to B2B inquiries and consultation requests through the Inquiry Form
  4. Answers to frequently asked questions (FAQ)
  5. Sharing of related information (brand, design and policies)

The Site does not offer direct sales, online ordering or payment for products. All product transactions are conducted only through separate B2B contracts or purchase orders (POs).

Article 5 (Use of the Service)

  1. Users can view information on the Site and submit inquiries without registering as members.
  2. As a rule, the Company operates the Site 24 hours a day, all year round; however, all or part of the Service may be temporarily suspended due to system maintenance, replacement or failure, power outages, communication failures, natural disasters or other force majeure events.
  3. Users must secure, at their own responsibility and expense, the devices, internet environment and other means needed to access the Site.

Article 6 (Nature of Posted Information and Limitation of Liability)

Important — The professional cosmetics information, academic materials, mechanisms of action and application-related information posted on the Site are provided solely for reference by medical professionals and are not a substitute for medical advice, diagnosis, or treatment for any patient.

  1. All scientific and academic content on the Site is information for academic reference, and decisions on whether and how to apply it in individual cases must be made under the responsibility of qualified professionals.
  2. The Company strives to ensure the accuracy of the information posted on the Site, but it is not liable for damages arising from the use of information as it stood before being updated to reflect academic developments, amendments to relevant laws or new scientific evidence after the time of posting.
  3. Before using information from the Site in actual application, users are obliged to check the product labeling, notices from the Ministry of Food and Drug Safety (MFDS) and relevant clinical guidelines themselves.

Article 7 (Obligations of Users)

Users must not engage in any of the following acts:

  1. Entering false information or misappropriating another person's information
  2. Using the Site's Content (text, images, designs, code, etc.) for reproduction, distribution, transmission, display, public transmission or the creation of derivative works without the Company's prior written consent
  3. Interfering with the normal operation of the Site (repeated automated access, unauthorized scraping, DDoS attacks, etc.)
  4. Defaming the Company or third parties or infringing their rights
  5. Any act that violates the law or these Terms

Article 8 (Intellectual Property Rights)

  1. Copyright and other intellectual property rights in the Content included on the Site (text, images, videos, shaders, designs, logos and trademarks) belong to the Company or the legitimate rights holders.
  2. The trademarks and brand marks displayed on the Site, such as CELLOGRAM, CLEARMED, Collagen Architecture, ECM Prime and Your Record, are business identifiers of the Company. Using them without the Company's prior written permission may constitute a violation of the Trademark Act or the Unfair Competition Prevention and Trade Secret Protection Act.
  3. Users may not use the Company's Content for commercial purposes without the Company's prior written consent.
  4. Academic citation and non-commercial use are permitted on the condition that the source (the Company's Site URL and publication date) is stated.

Article 9 (Exemption from Liability)

  1. The Company is not liable where it is unable to provide the Service due to force majeure events such as natural disasters, war, riots, terrorism, power outages, network failures or hacking.
  2. The Company is not liable for damages caused by reasons attributable to the user (entry of incorrect information, careless access control).
  3. The Company does not guarantee the accuracy or completeness of third-party information posted on the Site (academic papers, materials from external organizations, etc.), and users are responsible for checking the originals of the cited sources (PMID, DOI, etc.).
  4. The Company is not responsible for the content or accessibility of external links connected to the Site (academic databases, government agencies, certification bodies, etc.).

Article 10 (Protection of Personal Information)

The Company protects users' personal information in accordance with Korea's Personal Information Protection Act (PIPA) and other relevant laws, and the details are set out in the separate Privacy Policy. If these Terms and the Privacy Policy conflict, the Privacy Policy prevails with respect to matters concerning the processing of personal information.

Article 11 (Dispute Resolution)

  1. As a rule, any dispute arising between the Company and a user shall be resolved amicably through mutual consultation between the Company and the user.
  2. Notwithstanding the preceding paragraph, if a dispute is not resolved and a lawsuit is filed, the court having jurisdiction under the Civil Procedure Act or the Seoul Central District Court shall be the exclusive court of first instance.
  3. Matters not specified in these Terms are governed by relevant laws, such as the Act on the Consumer Protection in Electronic Commerce, the Act on the Regulation of Terms and Conditions, the Framework Act on Electronic Documents and Transactions, the Digital Signature Act, the Act on Promotion of Information and Communications Network Utilization and Information Protection, and the standard terms and conditions established by the Korea Fair Trade Commission, or by commercial practice.

Article 12 (Governing Law)

These Terms are interpreted and applied in accordance with the laws of the Republic of Korea. The laws of the Republic of Korea also govern disputes arising from the use of the Site by users outside Korea (provided, however, that where mandatory provisions of the relevant country take precedence, those provisions apply).

These Terms were written in Korean, and if a translation differs from the Korean version, the Korean version prevails.

Addenda

These Terms take effect on October 5, 2026.

Revision history

  • Effective October 5, 2026 (announced September 28, 2026) — this revision
  • Effective May 25, 2026 — first established

Before-and-after comparison for this revision

ProvisionBeforeAfter
Articles 2 and 4Service included "clinical materials" and "clinical data" / No direct sales, online ordering, payment or medical appointment booking for medical devices and cosmeticsCorrected to "academic materials" / No direct sales, online ordering or payment for products
Article 3(4)Continued use of the Site after the effective date deemed to be agreement to the amended TermsDeemed agreement removed — amended Terms apply from the effective date, and users who do not agree may stop using the Site
Article 6Title "Nature of Medical Information and Limitation of Liability"; medically oriented wording such as medical device and cosmetics information and clinical data; wording that framed who makes decisions around patient diagnosisTitle "Nature of Posted Information and Limitation of Liability"; "professional cosmetics information, academic materials, mechanisms of action and application-related information"; "decisions on whether and how to apply it in individual cases"
Article 8(2)Trademarks described as "registered or pending trademarks of the Company"Corrected to "business identifiers of the Company"
Article 12—Provision that the Korean version prevails added
Other"Draft" and "attorney review recommended" wordingRemoved (final version). The law cited in Article 11 corrected to its current name, the Framework Act on Electronic Documents and Transactions

Actual product transactions, contracts, confidentiality agreements and the like are governed by separate written agreements, independent of these Terms. Please send any questions about these Terms to contact@clearmed.co.kr.

Home
한국어 English 日本語 简体中文

© 2026 CLEARMED Co., Ltd. All rights reserved.